| Product Name | NebuSelect™ Recombinant Cynomolgus LRIG1, His-tag |
|---|---|
| Catalog Number | NBL-241524 |
| Alias/Synonyms | LRIG1 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | A0A2K5V8J9 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241524-100ug | 100ug | Inquire | Inquire | |
| NBL-241524-1mg | 1mg | Inquire | Inquire | |
| NBL-241524-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus LRIG1, His-tag
Catalog#:
NBL-241524
Description:
NebuSelect™ Recombinant Cynomolgus LRIG1, His-tag(Cat#NBL-241524) is expressed in HEK293 with His tag at the C-Terminus.It contains Ala34-Thr792.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 84.16 kDa. Due to glycosylation, the protein migrates to 90-110 kDa based on Bis-Tris PAGE result.
Target Name:
LRIG1
Target Information:
The leucine-rich repeats and immunoglobulin-like domains (LRIG)-1 is a tumor suppressor gene that belongs to the LRIG family. LRIG1 expression has prognostic significance in various human cancers. Somatic mutations, which are associated with a certain rate of response to targeted therapies, are ubiquitously found in human non-small cell lung cancer (NSCLC). LRIG1 was an independent prognostic factor for OS of NSCLC patients. LRIG1 in combination with other clinicopathological risk factors was a stronger prognostic model than clinicopathological risk factors alone.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.